Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Replay
Q3 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
11/05/14 at 8:30 a.m. ET
Q3 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
Wednesday, November 5, 2014 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Stifel 2014 Healthcare Conference
11/18/14 at 10:55 a.m. ET
Stifel 2014 Healthcare Conference
Tuesday, November 18, 2014 10:55 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Press Releases
More >>
11/24/14
ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia
11/06/14
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting
Investor Downloads

Download Documentation Corporate Presentation
More >>

ARIAD Stock Price: $7.11

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 11/25/14

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Down 0.04 (0.56%)
VOL8,456,900
OPEN$7.15
PREV. CLOSE$7.15
DAY HIGH$7.36
DAY LOW$7.05
52 WK. HIGH$9.83
Minimum 20 minute delay
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue